This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
CD81
From Proteopedia
| Line 1: | Line 1: | ||
| - | <StructureSection load='6u9s' size=' | + | <StructureSection load='6u9s' size='400' side='right' caption='Human CD81 (dark pink, cyan) complex with mouse antibody heavy chain (grey, yellow), light chain (green, light pink and glycerol (PDB code [[6ejm]])' scene='84/845937/Cv/1'> |
== Function == | == Function == | ||
Revision as of 13:08, 21 June 2020
| |||||||||||
3D structures of CD81
Updated on 21-June-2020
5tcx - hCD81 (mutant) - human
1g8q, 1iv5, 5m3t, 5m3d, 5m4r, 5m33, 5m2c, 3x0e, 3x0f - hCD81 extracellular domain 113-202
6ejm, 6ek2, 6ejg, 5dfw - hCD81 extracellular domain + Scfv
5dfv, 6u9s - hCD81 extracellular domain + antibody
3k0g - CD81 extracellular domain - green monkey
References
- ↑ Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol. 1998;16:89-109. doi: 10.1146/annurev.immunol.16.1.89. PMID:9597125 doi:http://dx.doi.org/10.1146/annurev.immunol.16.1.89
- ↑ Vences-Catalan F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK, Levy R, Levy S. CD81 is a novel immunotherapeutic target for B cell lymphoma. J Exp Med. 2019 Jul 1;216(7):1497-1508. doi: 10.1084/jem.20190186. Epub 2019 May , 23. PMID:31123084 doi:http://dx.doi.org/10.1084/jem.20190186
- ↑ Susa KJ, Seegar TC, Blacklow SC, Kruse AC. A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking. Elife. 2020 Apr 27;9. pii: 52337. doi: 10.7554/eLife.52337. PMID:32338599 doi:http://dx.doi.org/10.7554/eLife.52337
